{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:37:34Z","timestamp":1784003854877,"version":"3.55.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ejmech.2021.113340","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T20:53:52Z","timestamp":1615409632000},"page":"113340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Membrane active 7-thiazoxime quinolones as novel DNA binding agents to decrease the genes expression and exert potent anti-methicillin-resistant Staphylococcus aureus activity"],"prefix":"10.1016","volume":"217","author":[{"given":"Jin-Ping","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narsaiah","family":"Battini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Fawad","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-He","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113340_bib1a","doi-asserted-by":"crossref","first-page":"7923","DOI":"10.1021\/acs.jmedchem.9b01245","article-title":"Thiazoles, their benzofused systems, and thiazolidinone derivatives: versatile and promising tools to combat antibiotic resistance","volume":"63","author":"Cascioferro","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib1b","first-page":"1105","article-title":"Recent advances in application of thiazole compounds","volume":"42","author":"Cui","year":"2012","journal-title":"Sci. Sin. Chim."},{"key":"10.1016\/j.ejmech.2021.113340_sref1","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1007\/s00044-011-9685-2","article-title":"Thiazoles: having diverse biological activities","volume":"21","author":"Kashyap","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113340_bib2b","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejmech.2018.01.038","article-title":"Discovery of 2-aminothiazolyl berberine derivatives as effectively antibacterial agents toward clinically drug-resistant Gram-negative Acinetobacter baumanii","volume":"146","author":"Gao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib3","doi-asserted-by":"crossref","first-page":"112497","DOI":"10.1016\/j.ejmech.2020.112497","article-title":"Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections","volume":"202","author":"Shahin","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib4","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1021\/acsmedchemlett.7b00452","article-title":"Novel naphthalimide aminothiazoles as potential multitargeting antimicrobial agents","volume":"8","author":"Chen","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113340_bib5a","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113340_bib5b","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature17042","article-title":"Antibacterial drug discovery in the resistance era","volume":"529","author":"Brown","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113340_bib6a","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.aaj2191","article-title":"Antibiotic tolerance facilitates the evolution of resistance","volume":"355","author":"Levin-Reisman","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113340_bib6b","doi-asserted-by":"crossref","first-page":"10706","DOI":"10.1002\/anie.201209979","article-title":"Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials","volume":"52","author":"O\u2019Connell","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2021.113340_bib7a","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1002\/anie.201802416","article-title":"Structural view on medicinal chemistry strategies against drug resistance","volume":"58","author":"Agnello","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2021.113340_bib7b","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.bmcl.2018.06.016","article-title":"Azoalkyl ether imidazo[2,1-b]benzothiazoles as potentially antimicrobial agents with novel structural skeleton","volume":"28","author":"Maddili","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113340_bib8a","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1021\/acs.jmedchem.5b01678","article-title":"Novel 3-aminothiazolquinolones: design, synthesis, bioactive evaluation, SARs, and preliminary antibacterial mechanism","volume":"59","author":"Cui","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib8b","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ejmech.2016.10.011","article-title":"Multi-targeting exploration of new 2-aminothiazolyl quinolones: synthesis, antimicrobial evaluation, interaction with DNA, combination with topoisomerase IV and penetrability into cells","volume":"124","author":"Cheng","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejmech.2019.06.046","article-title":"A\u00a0new exploration towards aminothiazolquinolone oximes as potentially multi-targeting antibacterial agents: design, Synthesis and evaluation acting on microbes, DNA, HSA and topoisomerase IV","volume":"179","author":"Wang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib10a","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1128\/CMR.2.4.378","article-title":"Quinolone antimicrobial agents","volume":"2","author":"Wolfson","year":"1989","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2021.113340_bib10b","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules21040268","article-title":"The current case of quinolones: synthetic approaches and antibacterial activity","volume":"21","author":"Naeem","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113340_bib11a","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1016\/j.ejmech.2009.04.041","article-title":"Synthesis and in\u00a0vitro antibacterial activity of 7-(4-alkoxyimino-3-amino-3-methylpiperidin-1-yl)quinolone derivatives","volume":"44","author":"Chai","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib11b","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nsmb.1604","article-title":"Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases","volume":"16","author":"Laponogov","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2021.113340_bib12a","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ejmech.2018.08.061","article-title":"Quinolone derivatives and their activities against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"157","author":"Gao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib12b","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/cmdc.201700739","article-title":"Discovery of benzimidazole-quinolone hybrids as new cleaving agents toward drug-resistant Pseudomonas aeruginosa DNA","volume":"13","author":"Wang","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113340_bib13a","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ejmech.2019.06.071","article-title":"Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium antibacterial agents","volume":"179","author":"Fedorowicz","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib13b","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.4155\/fmc-2017-0108","article-title":"Antimicrobial 2-aminothiazolyl quinolones: what is their potential in the clinic?","volume":"9","author":"Gao","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejmech.2015.09.030","article-title":"Synthesis, antimycobacterial and antibacterial activity of quinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo)methylpyrrolidine moiety","volume":"104","author":"Zhang","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib15a","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ejmech.2017.11.082","article-title":"4-Quinolone derivatives and their activities against Gram-positive pathogens","volume":"143","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib15b","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejmech.2019.01.072","article-title":"Design and synthesis of aminothiazolyl norfloxacin analogues as potential antimicrobial agents and their biological evaluation","volume":"167","author":"Wang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib16a","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejmech.2016.01.052","article-title":"Discovery of membrane active benzimidazole quinolones-based topoisomerase inhibitors as potential DNA binding antimicrobial agents","volume":"111","author":"Zhang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib16b","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1021\/acs.molpharmaceut.8b01021","article-title":"Sulfonamide-derived four-component molecular hybrids as novel DNA-targeting membrane active potentiators against clinical Escherichia coli","volume":"16","author":"Hu","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2021.113340_bib17a","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1016\/j.bmcl.2015.06.041","article-title":"Design and biological evaluation of novel quinolone-based metronidazole derivatives as potent Cu2+ mediated DNA-targeting antibacterial agents","volume":"25","author":"Zhang","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113340_bib17b","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejmech.2014.08.063","article-title":"Novel hybrids of metronidazole and quinolones: synthesis, bioactive evaluation, cytotoxicity, preliminary antimicrobial mechanism and effect of metal ions on their transportation by human serum albumin","volume":"86","author":"Cui","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib17c","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/med.21290","article-title":"Comprehensive review in current developments of imidazole-based medicinal chemistry","volume":"34","author":"Zhang","year":"2014","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2021.113340_bib17d","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1360\/N032018-00098","article-title":"Researches and applications of nitroimidazole heterocycles in medicinal chemistry","volume":"49","author":"Li","year":"2019","journal-title":"Sci. Sin. Chim."},{"key":"10.1016\/j.ejmech.2021.113340_bib18a","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1016\/j.bmcl.2013.03.118","article-title":"Synthesis and biological evaluation of a class of quinolone triazoles as potential antimicrobial agents and their interactions with calf thymus DNA","volume":"23","author":"Cui","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113340_bib18b","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/1389557516666160630120725","article-title":"New progress in azole compounds as antimicrobial agents","volume":"17","author":"Zhang","year":"2017","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib18c","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/092986712803414213","article-title":"Recent researches in triazole compounds as medicinal drugs","volume":"19","author":"Zhou","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib19a","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1039\/C5MD00186B","article-title":"Design, synthesis, antibacterial evaluation of novel azolylthioether quinolones as MRSA DNA intercalators","volume":"6","author":"Zhang","year":"2015","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2021.113340_bib19b","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.2174\/15680266113139990125","article-title":"Recent developments in azole compounds as antibacterial and antifungal agents","volume":"13","author":"Peng","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1515\/HC.2004.10.6.447","article-title":"Syntheses of novel fluoroquinolone compounds","volume":"10","author":"Li","year":"2004","journal-title":"Heterocycl. Commun."},{"key":"10.1016\/j.ejmech.2021.113340_bib21a","doi-asserted-by":"crossref","first-page":"103487","DOI":"10.1016\/j.bioorg.2019.103487","article-title":"Synthesis and antibacterial evaluation against resistant Gram-negative bacteria of monobactams bearing various substituents on oxime residue","volume":"94","author":"Li","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib21b","doi-asserted-by":"crossref","first-page":"111595","DOI":"10.1016\/j.ejmech.2019.111595","article-title":"Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents","volume":"181","author":"Wang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ijantimicag.2016.06.026","article-title":"Ex\u00a0vivo efficacy of gemifloxacin in experimental keratitis induced by methicillin-resistant Staphylococcus aureus","volume":"48","author":"Marino","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2021.113340_bib23a","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s11426-015-0351-0","article-title":"Coumarin-derived azolyl ethanols: synthesis, antimicrobial evaluation and preliminary action mechanism","volume":"59","author":"Peng","year":"2016","journal-title":"Sci. China Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib23c","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1016\/j.bmc.2017.10.028","article-title":"Discovery of novel nitroimidazole enols as Pseudomonas aeruginosa DNA cleavage agents","volume":"25","author":"Li","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib23d","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s11426-016-9009-6","article-title":"Design, synthesis and biological evaluation of amino organophosphorus imidazoles as a new type of potential antimicrobial agents","volume":"60","author":"Gao","year":"2017","journal-title":"Sci. China Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib24a","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1039\/C8QO01180J","article-title":"Novel potential artificial MRSA DNA intercalators: synthesis and biological evaluation of berberine-derived thiazolidinediones","volume":"6","author":"Sun","year":"2019","journal-title":"Org. Chem. Front."},{"key":"10.1016\/j.ejmech.2021.113340_bib24b","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4155\/fmc-2017-0160","article-title":"Novel naphthalimide nitroimidazoles as multitargeting antibacterial agents against resistant Acinetobacter baumannii","volume":"10","author":"Kang","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib24c","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1021\/acsmedchemlett.7b00514","article-title":"Potential antimicrobial isopropanol-conjugated carbazole azoles as dual targeting inhibitors of Enterococcus faecalis","volume":"9","author":"Zhang","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113340_bib25a","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1021\/acsinfecdis.9b00100","article-title":"Dual inhibition of Klebsiella pneumoniae and Pseudomonas aeruginosa iron metabolism using gallium porphyrin and gallium nitrate","volume":"5","author":"Choi","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113340_bib25b","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ejmech.2018.06.022","article-title":"Novel carbazole-triazole conjugates as DNA-targeting membrane active potentiators against clinical isolated fungi","volume":"155","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib26","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.ejmech.2017.10.044","article-title":"Synthesis and bioactivities study of new antibacterial peptide mimics: the dialkyl cationic amphiphiles","volume":"143","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib27a","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.bmcl.2018.03.046","article-title":"Novel purine benzimidazoles as antimicrobial agents by regulating ROS generation and targeting clinically resistant Staphylococcus aureus DNA groove","volume":"28","author":"Wang","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113340_bib27b","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/cbdd.12532","article-title":"Design, synthesis, and antimicrobial evaluation of novel quinolone imidazoles and interactions with MRSA DNA","volume":"86","author":"Zhang","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2021.113340_bib27c","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.cclet.2017.04.002","article-title":"Novel potentially antibacterial naphthalimidederived metronidazoles: design, synthesis, biological evaluation and supramolecular interactions with DNA, human serum albumin and topoisomerase II","volume":"28","author":"Kang","year":"2017","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113340_bib27d","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1039\/C8MD00301G","article-title":"Novel organophosphorus aminopyrimidines as unique structural DNA targeting membrane active inhibitors towards drug-resistant methicillin-resistant Staphylococcus aureus","volume":"9","author":"Li","year":"2018","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2021.113340_bib28a","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1021\/acsinfecdis.9b00022","article-title":"Inhibitors of intracellular Gram-positive bacterial growth synthesized via povarov\u2212doebner reactions","volume":"5","author":"Dayal","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113340_bib28b","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejmech.2017.11.027","article-title":"Novel aminopyrimidinyl benzimidazoles as potentially antimicrobial agents: design, synthesis and biological evaluation","volume":"143","author":"Liu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib29","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1021\/acsmedchemlett.5b00368","article-title":"Discovery of pyrazolopyridones as a novel class of gyrase B inhibitors using structure guided design","volume":"7","author":"Cross","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113340_bib30a","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/jac\/dkq039","article-title":"Detection of mutations in the FemXAB protein family in oxacillin-susceptible mecA-positive Staphylococcus aureus clinical isolates","volume":"65","author":"Giannouli","year":"2010","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2021.113340_bib30b","first-page":"1612","article-title":"Influence of femB on methicillin resistance and peptidoglycan metabolism in","volume":"175","author":"Henze","year":"1993","journal-title":"Staphylococcus aureus"},{"key":"10.1016\/j.ejmech.2021.113340_bib31a","doi-asserted-by":"crossref","first-page":"8488","DOI":"10.1093\/nar\/gkr553","article-title":"The dimer state of GyrB is an active form: implications for the initial complex assembly and processive strand passage","volume":"39","author":"Wu","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2021.113340_bib31b","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ejmech.2019.06.093","article-title":"Indole-nitroimidazole conjugates as efficient manipulators to decrease the genes expression of methicillin-resistant Staphylococcus aureus","volume":"179","author":"Li","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib32","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1128\/AAC.38.11.2590","article-title":"Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in Staphylococcus aureus","volume":"38","author":"Lencastre","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113340_bib33a","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s11426-017-9169-4","article-title":"Discovery of natural berberine-derived nitroimidazoles as potentially multi-targeting agents against drug-resistant Escherichia coli","volume":"61","author":"Zhang","year":"2018","journal-title":"Sci. China Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib33b","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1039\/C7MD00112F","article-title":"Discovery of potential antifungal triazoles: design, synthesis, biological evaluation, and preliminary antifungal mechanism exploration","volume":"8","author":"Zhang","year":"2017","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2021.113340_bib33c","doi-asserted-by":"crossref","first-page":"126982","DOI":"10.1016\/j.bmcl.2020.126982","article-title":"Design and biological evaluation of a novel type of potential multi-targeting antimicrobial sulfanilamide hybrids in combination of pyrimidine and azoles","volume":"30","author":"Sui","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113340_bib34","article-title":"Synthesis and biological evaluation of quinazolonethiazoles as new potential conquerors towards Pseudomonas aeruginosa","volume":"39","author":"Wang","year":"2020","journal-title":"J.\u00a0Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib35","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.4155\/fmc-2019-0303","article-title":"An unexpected discovery toward novel membrane active sulfonyl thiazoles as potential MRSA DNA intercalators","volume":"12","author":"Hu","year":"2020","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113340_bib36","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1248\/cpb.55.894","article-title":"Synthesis and antibacterial activity of new N-[2-(thiophen-3-yl)ethyl] piperazinyl quinolones, Chem","volume":"55","author":"Bahram","year":"2007","journal-title":"Pharm. Bull."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421001896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421001896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:25:10Z","timestamp":1759328710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421001896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":68,"alternative-id":["S0223523421001896"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113340","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Membrane active 7-thiazoxime quinolones as novel DNA binding agents to decrease the genes expression and exert potent anti-methicillin-resistant Staphylococcus aureus activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113340"}}